Azathioprine (Imuran)
An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
Also Known As:
Imuran; Azathioprine Sodium; Azathioprine Sodium Salt; Azathioprine Sulfate; Azothioprine; Immuran; Imurel; Sodium, Azathioprine; 1H-Purine, 6-((1-methyl-4-nitro-1H-imidazol-5-yl)thio)-
Networked: 6086
relevant articles (833 outcomes,
633 trials/studies)
Relationship Network
Drug Context: Research Results
Experts
1. | Sandborn, William J:
24 articles
(07/2022 - 01/2002)
|
2. | de Boer, Nanne K H:
19 articles
(01/2022 - 04/2005)
|
3. | Gisbert, Javier P:
19 articles
(01/2019 - 06/2003)
|
4. | Mulder, Chris J J:
16 articles
(01/2022 - 01/2003)
|
5. | Pagnoux, Christian:
16 articles
(04/2020 - 09/2003)
|
6. | Rutgeerts, Paul:
15 articles
(08/2015 - 02/2002)
|
7. | Choe, Yon Ho:
13 articles
(11/2022 - 12/2010)
|
8. | Peyrin-Biroulet, Laurent:
13 articles
(07/2022 - 12/2008)
|
9. | Guillevin, Loïc:
13 articles
(03/2019 - 02/2008)
|
10. | Reinisch, Walter:
12 articles
(10/2021 - 10/2005)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures